Janux Therapeutics, Inc. (JANX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -12.34M | -28.54M | -12.86M | -23.81M | -17.02M | -16.73M | -2.23M | -10.02M | -14.84M | -9.9M | -11.71M | -15.05M | -13.91M | -11.91M | -13.41M | -6.07M | -11.52M | -10.48M | -5.85M | -6.2M |
| Operating CF Margin % | -330.48% | -362.21% | -128.56% | - | - | - | -508.2% | -112.63% | -1185.06% | -402.32% | -465.2% | -1424.22% | -679.25% | -418.73% | -739.88% | -256.79% | -725.11% | -648.58% | -505.09% | -1287.14% |
| Operating CF Growth % | 27.53% | -70.65% | -476.24% | -137.63% | -14.74% | -68.92% | 80.95% | 33.43% | -6.66% | 16.89% | 12.71% | -147.88% | -20.73% | -13.66% | -129.14% | 2.11% | -307.12% | -543.4% | - | - |
| Net Income | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -11.76M | -11.57M | -17.51M | -17.46M | -16.07M | -16.7M | -16.89M | -13.41M | -13.42M | -10.77M | -6.21M |
| Depreciation & Amortization | 0 | 468K | 501K | 541K | 519K | 512K | 510K | 506K | 532K | 531K | 500K | 471K | 453K | 403K | 249K | 108K | 81K | 64K | 27K | 13K |
| Stock-Based Compensation | 0 | 9.52M | 9.04M | 10.96M | 10.7M | 6.25M | 15.39M | 5.76M | 5.63M | 4.48M | 4.55M | 5.5M | 5.47M | 4.21M | 4.6M | 4.44M | 3.96M | 2.94M | 2.57M | 1.28M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 7.11M | -3.52M | -4.62M | -5.21M | -4.22M | -2.93M | -2.9M | -2.97M | -1.79M | -2.06M | -2.11M | -1.84M | -1.68M | -1.29M | -768K | -99K | -24K | -58K | -79K | -32K |
| Working Capital Changes | 4.91M | -3.06M | 6.54M | 3.75M | -516K | -345K | 12.83M | -7.35M | -4.45M | -1.1M | -3.08M | -1.68M | -700K | 836K | -795K | 6.36M | -2.13M | -15K | 2.4M | -1.26M |
| Change in Receivables | -35M | 0 | 0 | 0 | 0 | 0 | 0 | -6.98M | -519K | 0 | 0 | 750K | -750K | 500K | -500K | 0 | 0 | 0 | 375K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.61M | 1.67M | -168K | 1.11M | -1.64M | 1.56M | 1.18M | -694K | -456K | 327K | 228K | -171K | -107K | 223K | -634K | 857K | -740K | -482K | 2.58M | -310K |
| Cash from Investing | 8.29M | 29.54M | 8.31M | 1.56M | -340.39M | 33.93M | 12.67M | -190.88M | -113.74M | 11.12M | -61.45M | 17.87M | -8.74M | -1.6M | 19.76M | 9.04M | 31.07M | 7.33M | -205.54M | -142.6M |
| Capital Expenditures | -273K | -106K | -93K | -473K | -371K | -42K | -25K | -95K | -197K | -515K | -470K | -580K | -285K | -2.06M | -2.52M | -898K | -971K | -1.17M | -77K | -79K |
| CapEx % of Revenue | 7.31% | 1.35% | 0.93% | - | - | - | 5.69% | 1.07% | 15.73% | 20.93% | 18.67% | 54.87% | 13.92% | 72.27% | 139% | 37.97% | 61.11% | 72.59% | 6.64% | 16.39% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.64M | 60.98M | 0 | 0 | 0 | -22.28M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.64M | -60.98M | 0 | 0 | 0 | 22.28M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.54M | 2.94M | 493K | 954K | 554K | 386.65M | 1.65M | 2.77M | 322.17M | 831K | 56.61M | 528K | 1.58M | 191K | 0 | 308K | 1K | 164K | -843K | 329.66M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 3.54M | 2.94M | 493K | 954K | 554K | 378.21M | 1.65M | -455K | 320.51M | 831K | 56.53M | 0 | 1.58M | 0 | 0 | 308K | 1K | 164K | -843K | 124.55M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 8.44M | 0 | 3.22M | 1.66M | 0 | 79K | 528K | 0 | 191K | 0 | 0 | 0 | 0 | 0 | 205.11M |
| Net Change in Cash | -506K | 3.94M | -4.06M | -21.3M | -356.86M | 403.85M | 12.09M | -198.14M | 193.6M | 2.05M | -16.55M | 3.35M | -21.07M | -13.33M | 6.35M | 3.27M | 19.55M | -3.81M | -212.24M | 180.86M |
| Free Cash Flow | -12.61M | -28.65M | -12.95M | -24.29M | -17.39M | -16.77M | -2.26M | -10.12M | -15.03M | -10.42M | -12.18M | -15.63M | -14.2M | -13.97M | -15.93M | -6.97M | -12.49M | -11.65M | -5.93M | -6.28M |
| FCF Margin % | -337.8% | -363.55% | -129.49% | - | - | - | -513.9% | -113.7% | -1200.8% | -423.24% | -483.87% | -1479.09% | -693.16% | -491% | -878.87% | -294.76% | -786.22% | -721.16% | -511.73% | -1303.53% |
| FCF Growth % | 27.51% | -70.86% | -473.98% | -140.08% | -15.7% | -60.97% | 81.48% | 35.29% | -5.9% | 25.43% | 23.57% | -124.27% | -13.63% | -19.86% | -168.66% | -10.95% | -330.92% | -615.41% | - | - |
| FCF per Share | -0.20 | -0.46 | -0.21 | -0.39 | -0.28 | -0.30 | -0.04 | -0.19 | -0.31 | -0.22 | -0.27 | -0.37 | -0.34 | -0.34 | -0.38 | -0.17 | -0.30 | -0.28 | -0.14 | -0.63 |
| FCF Conversion (FCF/Net Income) | 0.51x | 0.89x | 0.53x | 0.70x | 0.72x | 0.83x | 0.08x | 1.68x | 1.01x | 0.84x | 1.01x | 0.86x | 0.80x | 0.74x | 0.80x | 0.36x | 0.86x | 0.78x | 0.54x | 1.00x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |